Log in to save to my catalogue

Rspo2 exacerbates rheumatoid arthritis by targeting aggressive phenotype of fibroblast-like synovioc...

Rspo2 exacerbates rheumatoid arthritis by targeting aggressive phenotype of fibroblast-like synovioc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A772249562

Rspo2 exacerbates rheumatoid arthritis by targeting aggressive phenotype of fibroblast-like synoviocytes and disrupting chondrocyte homeostasis via Wnt/[beta]-catenin pathway

About this item

Full title

Rspo2 exacerbates rheumatoid arthritis by targeting aggressive phenotype of fibroblast-like synoviocytes and disrupting chondrocyte homeostasis via Wnt/[beta]-catenin pathway

Publisher

BioMed Central Ltd

Journal title

Arthritis research & therapy, 2023-11, Vol.25 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background The aggressive phenotype of fibroblast-like synoviocytes (FLS) has been identified as a contributing factor to the exacerbation of rheumatoid arthritis (RA) through the promotion of synovitis and cartilage damage. Regrettably, there is currently no effective therapeutic intervention available to address this issue. Recent research has sh...

Alternative Titles

Full title

Rspo2 exacerbates rheumatoid arthritis by targeting aggressive phenotype of fibroblast-like synoviocytes and disrupting chondrocyte homeostasis via Wnt/[beta]-catenin pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A772249562

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A772249562

Other Identifiers

ISSN

1478-6354

DOI

10.1186/s13075-023-03198-1

How to access this item